Smart Patients is an online community for patients and their families. Join us to talk with other patients about the latest research for your condition.

Biology of Osteosarcoma (BOOST) Registry and Biobank

Overview

Status Recruiting
Sponsor University of Minnesota
Start date January 2017
End date December 2050
Enrollment 5000 participants
Identifiers NCT03225872, 2016NTLS073

Conditions

Osteosarcoma

Treatments

Summary

Osteosarcoma is very rare cancer of the bone. The investigator started the BOOST registry and biobank to make sure every patient has the opportunity to participate in research.

Recruiting in the following locations

US States Minnesota
Other countries None
Masonic Cancer Center
Minneapolis, Minnesota Recruiting
Worldwide

Inclusion Criteria

» Proband Inclusion criteria: A diagnosis or suspected diagnosis of osteosarcoma (ICCC 9180-9200) Family member inclusion criteria: Biological parents and full biological siblings of a case diagnosed with osteosarcoma (ICCC 9180-9200)

Exclusion Criteria

» Does not understand English.
Trial information was received from ClinicalTrials.gov and was last updated on March 5, 2024. This information was provided to ClinicalTrials.gov by University of Minnesota on October 2, 2023.